Long-Term Outcome of Indomethacin Treatment in Pediatric Patients with Paroxysmal Hemicrania—A Case Series
Open Access
- 3 February 2021
- Vol. 8 (2), 101
- https://doi.org/10.3390/children8020101
Abstract
Paroxysmal Hemicrania is a rare form of primary headache in children and adolescents, belonging to the group of trigeminal autonomic cephalalgias. Patients suffer from severe, short-lasting unilateral headaches accompanied by symptoms of the autonomic system on the same side of the head. The short duration of attacks distinguishes Paroxysmal Hemicrania from other trigeminal autonomic cephalalgias. Indomethacin is the treatment of choice, and its effectiveness provides a unique diagnostic criterion. However, the long-term outcomes in children are highly underreported. In this case-series, n = 8 patients diagnosed with Paroxysmal Hemicrania were contacted via telephone 3.1 to 10.7 years after initial presentation. A standardized interview was conducted. n = 6 patients were headache-free and no longer took indomethacin for 5.4 ± 3.4 years. The mean treatment period in these patients was 2.2 ± 1.9 years. Weaning attempts were undertaken after 1.7 ± 1.3 months; in n = 3 patients, more than one weaning attempt was necessary. n = 2 patients were still taking indomethacin (4.5 and 4.9 years, respectively). Both unsuccessfully tried to reduce the indomethacin treatment (two and six times, respectively). Adverse effects appeared in n = 6 (75%) patients and led to a discontinuation of therapy in n = 2 patients. Our long-term follow-up suggests that in a substantial proportion of pediatric patients, discontinuing indomethacin therapy is possible without the recurrence of Paroxysmal Hemicrania.This publication has 27 references indexed in Scilit:
- P047. Paroxysmal episodic hemicrania in a child. A complex differential diagnosis.The Journal of Headache and Pain, 2015
- Pediatric paroxysmal hemicrania: a case report and some clinical considerationsNeurological Sciences, 2015
- A potential nitrergic mechanism of action for indomethacin, but not of other COX inhibitors: relevance to indomethacin-sensitive headachesThe Journal of Headache and Pain, 2010
- Global shortage and rationing of indomethacin: need to refine approachJournal of Perinatology, 2010
- Paroxysmal Hemicrania in Children—Symptoms, Diagnostic Criteria, Therapy and OutcomeCephalalgia, 2009
- Trigeminal Autonomic Cephalalgias: Current and Future TreatmentsHeadache: The Journal of Head and Face Pain, 2007
- Psychiatric side effects of indomethacin in parturientsCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2003
- Central Nervous System Side Effects of Nonsteroidal Anti-inflammatory DrugsArchives of Internal Medicine, 1991
- Chronic Paroxysmal Hemicrania: A Case Report: Long-Lasting Remission in The Chronic StageCephalalgia, 1987
- Chronic Paroxysmal Hemicrania: Continued Remission of Symptoms after Discontinuation of IndomethacinCephalalgia, 1982